| Tag | Content |
|---|
EnhancerAtlas ID | HS109-04947 |
Organism | Homo sapiens |
Tissue/cell | Kasumi-1 |
Coordinate | chr11:124939530-124941100 |
TF binding sites/motifs | | TF | JASPAR ID | Coordinate | Motif Sequence | Strand | -Log10(p-value) |
| Myod1 | MA0499.1 | chr11:124939658-124939671 | GGAGACAGCTGCA | - | 6.24 | | Myog | MA0500.1 | chr11:124939661-124939672 | GACAGCTGCAG | + | 6.62 | | RREB1 | MA0073.1 | chr11:124941022-124941042 | GGTGTGTGTGTGGGGTGGGG | - | 6.68 | | Tcf12 | MA0521.1 | chr11:124939661-124939672 | GACAGCTGCAG | + | 6.14 |
|
| | Number of super-enhancer constituents: 4 | ID | Coordinate | Tissue/cell |
| SE_01413 | chr11:124939264-124943470 | Adrenal_Gland | | SE_09613 | chr11:124937388-124944104 | CD14 | | SE_28104 | chr11:124937730-124946159 | Fetal_Intestine | | SE_29398 | chr11:124938292-124946310 | Fetal_Intestine_Large |
|
| | Diseases: AD,Huntington,Obesity,Parkinson,Prostate cancer,Schizophrenia and Sleep disorder | | Number of disease enhancers: 1 | Chromosome | Start | End |
|
| | Number: 1 | ID | Chromosome | Start | End |
| GH11I125068 | chr11 | 124938196 | 124946379 |
|
Enhancer Sequence | CAGCAAAGGC ATGCAAGTGG AGACATGGCC TGTCCCCTGT CTCTGAAGTA GTAACATGTA 60
GCTCCAGCTG GTAGGAACAA AAGGTGCCCC TGGACAGGAG GCTGGGAGTC ATGTGGCGCC 120
AGGTGTGTGG AGACAGCTGC AGACATCCAG GCAAGAGTCA GAGATGGCGG AGTTTCTGTC 180
CAGGAAGATG TTGCTCTCCT CCTCCTGTTA GGCCTTCCTC GTCAGGATGA CAATGAATGG 240
CTTGTCCATG GCGTTTCAGA GCCACAGAGC ACCTGGAGGT TCCCCAGCCT GGAGCCTGGC 300
TGGTTCCTGC CTTTTGTACC AGTGTCTGTG TGGGTGCGTC TGGGGGCAGC TGGCAGCATG 360
GGAGATGACT GTGGCTGGTG CTTATGGGGC TGGGCCCATT TCCTGGGGCC CTCTGAGGGG 420
GATGGCCCAG AACGTGCAGA AGAAGAGCCT GTGGGAGGAA ATACCAGGGT GACCACAGCT 480
GGATGAGCAG GAATGGGCAG GAGGGTGAAT TGGGCAGGCA GGAAGAGCAG GAGCTGTGAG 540
CTCCTGTGGT GCCATTTTTC CCACACCTCG ATCTTCCCCT GTGAGCTGCA AAAGGCCACA 600
GCTGAGCTAG AATGGATGGT TCTGCCCTGT GGAGTTAGCT AAGGGCTTTC ACTGCCGGAT 660
CCTGGTGCCC ACTCTGAGGA GGACGCAGGG GAAAGACATT CAAATTCATA CTGAGAGAAA 720
ATCTGCTGTG TGCCAGACAC TTCCACATCC AGGATATCTC ATTTAATCTT TATAACACTC 780
TCGTGCAGCA GGGGAATATG ATCTTATTTA AAGGAAGATC GAACTGAGGC TTAGAGACGT 840
ACAACAACTT GCCCAAGGTC ACATTAAGTG GCAGAACCAG AAATTAGGAC TCAGCCAATT 900
TTGCTCGAAG TCTGATGTCT GTTTCCCTGT CCTATGGGCT AGCTCTCTCA AATCTTACTT 960
TCCTGTTGAC TGCAAAGAGG TGCATGGTAA GGGCAGCAGA AAGGGCTGTT TAAAATGAGC 1020
TTTGATGGGA AGAGGCTGCT TGGAAAAGGA AATGAGGGCT CCTGGGGAGA ACCTGGAGTC 1080
TCAGCCCATG ATCCCTACTC CGGCCCCCCA GAAGGGGCAT GTGAGCCTGT GGAGGTCCCA 1140
TCCCCCACCC CTCGTGACAG CAGCTTCTCC CCCAGCTGCT TTTTGGGCTT CCTCTTCCAC 1200
CCTGCTGTTT CCTCTCTCCC TCCCTACAGT GGACTGGCGT GCACCTCATT GACCTCGGGT 1260
GGGGCTGTCT GACTCAGGCC CTGTGGGCTG GTCTAGAAGG TAGCAGCAAG GTTTCGAAAT 1320
AGTCTGTATG GTTGGCCAAG GCCTTGTTTT TTCCATTCAA GCTTCTGTAT CAACTGAGAG 1380
CTGGGGTCAG GGTTGACAGT CCCAAAGTAA CAGCAGAATT GAGGACAGAC ACCAGAGGTA 1440
GAGTCCCTGA AGCCCAGGAC CTCCTATCTG AGTCACTAAC AGACACTAAG TTGGTGTGTG 1500
TGTGGGGTGG GGGGGCGGTG TCACTGCTCT CCTGTTGGCT TCTGGCTCAG GTCTTGTCCC 1560
CTGGACGCTT 1570
|
